Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
American Health Foundation Patents
Assignee:
American Health Foundation
Address:
Valhalla, NY
No. of patents:
12
Patents:












Patent Number Title Of Patent Date Issued
6433011 Method for inhibiting formation of aberrant crypt foci in the colon of a mammal August 13, 2002
A method is provided for inhibiting the development of colon tumorigenesis in a mammal by administering to the mammal a pharmacologically effective amount of an isothiocyanate selected from the group consisting of sulforaphane and phenethyl isothiocyanate.
5741678 Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out t April 21, 1998
There is disclosed a quantitative sensitive method to enable the detection of point mutations at a known site to a diagnostic kit which uses a multi step (for example, four steps) or a single step reaction. The method uses selective polymerase chain reaction (PCR) amplification of mutant
5626738 Methods for the separation and detection of nitrosothiols May 6, 1997
A method for detecting a nitrosothiol in an eluant from a chromatographic process including passing the eluant through a series of electrodes comprising an upstream working electrode and a downstream working electrode. The upstream working electrode is maintained at a potential adequ
5512441 Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the April 30, 1996
There is disclosed a quantitative sensitive method to enable the detection of point mutations at a known site to a diagnostic kit which uses a multi step (for example, four steps) or a single step reaction. The method uses selective polymerase chain reaction (PCR) amplification of mutant
5391568 Inhibition of lung tumorigenesis by administration of a polyphenol February 21, 1995
A method is provided for reducing the incidence of lung cancer in a mammal by administering thereto a pharmacologically effective amount of epigallocatechin gallate (EGCG). The EGCG may be administered to the mammal in the form of drinking water and particularly in the form of, for e
5260283 Method for altering excretion of estrogens or lipids in mammals November 9, 1993
Wheat bran fiber is used to alter the enterohepatic recirculation of estrogens leading to an increased fecal excretion of estrogens together with a decrease in urinary excretion of estrogens. Increased lipid excretion is also found. Thus wheat bran fiber is useful to remove estrogen
5231209 Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same July 27, 1993
A method of inhibiting lung tumor multiplicity and/or incidence by treating mammals with relatively long chain arylalkyl isothiocyanates, especially effective with respect to tumors induced by exposure to tobacco-specific nitrosamine. Among the isothiocyanates are 4-phenylbutyl isothiocy
5114969 Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same May 19, 1992
A method of inhibiting lung tumor multiplicity and/or incidence by treating mammals with relatively long chain arylalkyl isothiocyanates, especially effective with respect to tumors induced by exposure to tobacco-specific nitrosamine. Among the isothiocyanates are 4-phenylbutyl isothiocy
5011697 Inhibiting development of mutagens and carcinogens April 30, 1991
L-Tryptophan is applied to foodstuff to prevent the development of mutagens/carcinogens. Before the cooking of a foodstuff such as hamburger, L-Tryptophan is applied to the surfaces thereof to inhibit, for example, the generation of IQ type carcinogens. The L-Tryptophan can be sprinkled
4988517 Method and composition for inhibiting colon carcinogenesis January 29, 1991
It is shown that benzylselenocyanate in the diet significantly inhibits the incidence (percentage of animals with tumors) and multiplicity (number of tumors per animal) of adenocarcinomas in the colon and multiplicity of adenocarcinomas in the small intestine compared to those fed a cont
4923813 Monoclonal antibody-based immunoassay for cyclic DNA adducts resulting from exposure to crotonal May 8, 1990
Monoclonal antibodies specific for the 8R,6R- and 8S,6S-stereoisomers of 3-(2-deoxy-.beta.-D-erythropentofuransyl)-5,6,7,8-tetrahydro-8-hydroxy-6-m ethylpyrimido[1,2-a]purine-10(3H)one were produced. These cyclic 1,N.sup.2 -propanodeoxyguanosines are formed in DNA exposed to crotonaldehyd
4777052 Method of treating a foodstuff to inhibit the development of mutagens and related product October 11, 1988
L-Tryptophan is applied to foodstuff to prevent the development of mutagens/carcinogens. Before the cooking of a foodstuff such as hamburger, L-Tryptophan is applied to the surfaces thereof to inhibit, for example, the generation of IQ type carcinogens. The L-Tryptophan can be sprinkled

 
 
  Recently Added Patents
Wafer level package and fabrication method
Antagonists of the glucagon receptor
Method for resource allocation in a wireless communication network, method for error-free transmission of information, node and wireless communication network
Imaging lens with three lens elements, and electronic apparatus having the same
Tint block image generation program and tint block image generation device
Pre-distortion architecture for compensating non-linear effects
Semiconductor device
  Randomly Featured Patents
Vehicle backward movement detection apparatus and vehicle braking force control apparatus
Transparent optimization for transmission control protocol flow control
Method and system for acoustic upgrading of firmware
Torque limiting overload coupling
Connector device for IC card
Pyrimidine derivatives, processes for preparation thereof and composition containing the same
Soybean cultivar S010345
Method and apparatus for thickness determination in multilayer articles
Adjustable sundial
Eyeglass strap retainer device